Clinical Trials Directory

Trials / Completed

CompletedNCT02952846

Tapering of Analgosedation and Occurrence of Withdrawal Syndrome in Paediatric Intensive Care Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is a prospective interventional study with three main aims: 1. Describe the frequency and severity of withdrawal syndrome in a population of paediatric intensive care patients. 2. Test whether implementation of an algorithm for tapering of analgosedation changes the frequency and severity of withdrawal symptoms in the same population. 3. Investigate how the health care providers experience having to adhere to such an algorithm.

Detailed description

Patients \< 18 years of age treated in an intensive care unit for 5 days or more with infusion of opioids and/or benzodiazepines, are eligible for inclusion. Patients are included at the time tapering of these drugs is initiated. Part one of the study is observational. Drugs administered, complications, Comfort score and WAT-1 (Withdrawal Assessment Tool-1) score is recorded. Before part two of the study, an algorithm for tapering of analgosedation is implemented, and the data set is obtained as in part one. For part three of the study, focus group interviews will be used.

Conditions

Interventions

TypeNameDescription
OTHERAlgorithm for tapering og analgosedationAlgorithm for tapering og analgosedation

Timeline

Start date
2016-05-01
Primary completion
2022-04-19
Completion
2022-04-19
First posted
2016-11-02
Last updated
2022-04-27

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02952846. Inclusion in this directory is not an endorsement.